Micafungin

Common brands: Micafungin, Mycamine, Vancomycin, Meropenem, Tyzavan

Top reporter: Fresenius Kabi Usa, Llc

Echinocandin Antifungal [EPC]Azole Antifungal [EPC]Corticosteroid [EPC]Glycopeptide Antibacterial [EPC]Penem Antibacterial [EPC]
8,257
Total Reports
4,802
Serious Reports
2,742
Death Reports
30
Reported Reactions
Death Report Ratio: High (33.21%)

Patient Demographics

Male
4,566
Female
2,985

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Micafungin.

# Reaction Reports % of Total
1 OFF LABEL USE 1,189
12.9%
2 DRUG INEFFECTIVE 1,122
12.1%
3 FEBRILE NEUTROPENIA 539
5.8%
4 PYREXIA 524
5.7%
5 PRODUCT USE IN UNAPPROVED INDICATION 393
4.2%
6 SEPSIS 350
3.8%
7 PNEUMONIA 329
3.6%
8 DEATH 311
3.4%
9 DIARRHOEA 294
3.2%
10 NEUTROPENIA 275
3.0%
11 MULTIPLE ORGAN DYSFUNCTION SYNDROME 272
2.9%
12 ACUTE KIDNEY INJURY 258
2.8%
13 RESPIRATORY FAILURE 256
2.8%
14 SEPTIC SHOCK 237
2.6%
15 APLASTIC ANAEMIA 228
2.5%
16 FUNGAL INFECTION 223
2.4%
17 ANAEMIA 215
2.3%
18 CONDITION AGGRAVATED 200
2.2%
19 INFECTION 195
2.1%
20 RENAL FAILURE 191
2.1%
21 BRONCHOPULMONARY ASPERGILLOSIS 185
2.0%
22 NAUSEA 176
1.9%
23 CANDIDA INFECTION 174
1.9%
24 MUCOSAL INFLAMMATION 169
1.8%
25 ASPERGILLUS INFECTION 164
1.8%
26 PRODUCT USE ISSUE 159
1.7%
27 THROMBOCYTOPENIA 158
1.7%
28 HYPOTENSION 157
1.7%
29 RENAL IMPAIRMENT 155
1.7%
30 PLATELET COUNT DECREASED 153
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.